Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
FDA Rolls Out 5-Year Plan for Addressing Rare Neurodegenerative Diseases
07/06/2022
Jolynn Tumolo
The US Food and Drug Administration (FDA) recently announced its 5-year Action Plan for Rare Neurodegenerative Diseases including Amyotrophic Lateral Sclerosis (ALS).
The US Food and Drug Administration (FDA) recently announced its 5-year Action Plan for Rare Neurodegenerative Diseases including Amyotrophic Lateral Sclerosis (ALS).
The US Food and Drug...
07/06/2022
Neurology
News
Cognitive Improvement Helps Drive Function Gains in Patients With Schizophrenia
07/05/2022
Jolynn Tumolo
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially...
07/05/2022
Psych Congress Network
News
Current Depression Associated With Increased Cardiovascular Risk
07/05/2022
Jolynn Tumolo
Primary care patients with current depression had significantly higher cardiovascular risk compared with patients with controlled depression and patients without depression, according to study findings.
Primary care patients with current depression had significantly higher cardiovascular risk compared with patients with controlled depression and patients without depression, according to study findings.
Primary care patients with...
07/05/2022
Psych Congress Network
News
Telecommunication Tech May Improve PrEP Adherence in Black, Latino Individuals
07/05/2022
Jolynn Tumolo
Researchers analyzed the effectiveness of mobile health, telehealth, and e-health technology for improving uptake, adherence, and persistence of PrEP among vulnerable patient populations.
Researchers analyzed the effectiveness of mobile health, telehealth, and e-health technology for improving uptake, adherence, and persistence of PrEP among vulnerable patient populations.
Researchers analyzed the...
07/05/2022
First Report Managed Care
News
FDA Advisory Committee Recommends Approval of Adrenoleukodystrophy Treatment
07/01/2022
Jolynn Tumolo
An FDA advisory panel unanimously recommended the approval of the investigational gene therapy elivaldogene autotemcel (eli-cel) for the treatment of early active cerebral adrenoleukodystrophy in pediatric patients.
An FDA advisory panel unanimously recommended the approval of the investigational gene therapy elivaldogene autotemcel (eli-cel) for the treatment of early active cerebral adrenoleukodystrophy in pediatric patients.
An FDA advisory panel...
07/01/2022
Neurology
News
Nonradiographic Axial Spondyloarthritis Differs in Men and Women
06/30/2022
Jolynn Tumolo
Findings showed women with nonradiographic axial spondyloarthritis (nraxSpA) had a lower average polygenic risk score and lower HLA-B27 prevalence when compared to men with nraxSpA. 
Findings showed women with nonradiographic axial spondyloarthritis (nraxSpA) had a lower average polygenic risk score and lower HLA-B27 prevalence when compared to men with nraxSpA. 
Findings showed women with...
06/30/2022
First Report Managed Care
News
Treatment Shows Early Effectiveness in Real-World Patients With Severe Asthma
06/30/2022
Jolynn Tumolo
Patients experienced improvements in asthmatic symptoms, lung function, and fractional exhaled nitric oxide after treatment with a monoclonal antibody.
Patients experienced improvements in asthmatic symptoms, lung function, and fractional exhaled nitric oxide after treatment with a monoclonal antibody.
Patients experienced...
06/30/2022
First Report Managed Care
News
Treatment Effective for Severe Narcolepsy Symptoms
06/30/2022
Jolynn Tumolo
A histamine 3 receptor antagonist/inverse agonist was highly effective in reducing excessive daytime sleepiness and cataplexy in adults with severe narcolepsy symptoms, according to findings presented at Sleep 2022.
A histamine 3 receptor antagonist/inverse agonist was highly effective in reducing excessive daytime sleepiness and cataplexy in adults with severe narcolepsy symptoms, according to findings presented at Sleep 2022.
A histamine 3 receptor...
06/30/2022
First Report Managed Care
News
Immunization Uptake Higher When Pharmacists Are Involved
06/30/2022
Jolynn Tumolo
Immunization rates are positively impacted by pharmacist participation in immunization efforts, according to study authors.
Immunization rates are positively impacted by pharmacist participation in immunization efforts, according to study authors.
Immunization rates are...
06/30/2022
Pharmacy Learning Network
News
First Aid Antiseptic Recalled Over Leaky Containers
06/30/2022
Jolynn Tumolo
Vi-Jon LLC is voluntarily recalling 3 million bottles of isopropyl alcohol due to defective containers.
Vi-Jon LLC is voluntarily recalling 3 million bottles of isopropyl alcohol due to defective containers.
Vi-Jon LLC is voluntarily...
06/30/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use